Patent 8426401 was granted and assigned to Janssen Pharmaceuticals on April, 2013 by the United States Patent and Trademark Office.
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows: